...
首页> 外文期刊>Der Pharmacia Lettre >Formulation and development of gastroretentive multi-layer coatedtablets containing Gatifloxacin against H.pylori infection
【24h】

Formulation and development of gastroretentive multi-layer coatedtablets containing Gatifloxacin against H.pylori infection

机译:含加替沙星的幽门螺杆菌胃滞留多层包衣片剂的研制与开发

获取原文
           

摘要

Floating multi-layer coated tablets were formulated based on gas formation. The system consists of a drug containing core tablet coated with a protective layer (Hydroxy Propyl Methyl Cellulose-HPMC), a gas forming layer (sodium bicarbonate) and a gas-entrapped membrane, respectively. Eudragit RL 30D was chosen as a gas-entrapped membrane due high water permeability and low CO2 permeability. The obtained tablets showed the buoyancy due to the CO2 gas formation and the gas entrapment by polymeric membrane of Eudragit RL 30D. The effect of formulation variables on floating properties and drug release was investigated. The floating tablets using direct-compressed cores had shorter time to float and faster drug release than those using wet-granulated cores. The increased ratio of sodium bicarbonate to HPMC increased the drug release from the floating tablets while increasing coating level of gasentrapped membrane increased floating lag time. Good floating properties and sustained drug release were achieved. These floating tablets seem to be a promising floating gastroretentive drug delivery system which can be targeted in stomach to eradicate H.pylori infection.
机译:漂浮的多层包衣片剂是基于气体形成来配制的。该系统由涂有保护层(羟丙基甲基纤维素-HPMC),气体形成层(碳酸氢钠)和气体截留膜的含药核心片剂组成。 Eudragit RL 30D因其高水渗透性和低CO2渗透性而被选作阻气膜。所得片剂由于Eudragit RL 30D的聚合物膜的CO2气体形成和气体截留而显示出浮力。研究了制剂变量对漂浮性能和药物释放的影响。与使用湿法制粒的核心相比,使用直接压制核心的漂浮片剂具有更短的漂浮时间和更快的药物释放。碳酸氢钠与HPMC的比例增加,则可从漂浮片中释放出更多的药物,而增加气相包裹膜的包衣水平则可以增加漂浮滞后时间。获得了良好的漂浮性和持续的药物释放。这些漂浮的片剂似乎是有希望的漂浮的胃滞留药物递送系统,其可以靶向胃以根除幽门螺杆菌感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号